Altered dynamics of intestinal cell maturation in APC1638N/+ mice

Cancer Research

Volumn 70, Issue 13, 2010, Pages 5348-5357

  Wang, Donghai ^a,c   Pezo, Rossanna C ^a,b   Corner, Georgia ^a,c   Sison, Cristina ^d   Lesser, Martin L ^d   Shenoy, Shailesh M ^a,b   Mariadason, John M ^e   Singer, Robert H ^a,b   Augenlicht, Leonard H ^a,b,c  

^a Department of Medicine ^*  (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^c MONTEFIORE MEDICAL CENTER   (United States)

^d FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH   (United States)

^e AUSTIN HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

TRICARBOXYLIC ACID;

ANIMAL TISSUE; ARTICLE; CANCER GROWTH; CELL MATURATION; CONTROLLED STUDY; DOWN REGULATION; GENE ACTIVATION; GENE EXPRESSION; GENE LOCUS; GENE REPRESSION; GENE SEQUENCE; GENE TARGETING; GENETIC CODE; GENETIC TRANSCRIPTION; HIF1ALPHA GENE; HISTOPATHOLOGY; INTESTINE MUCOSA; MATH1 GENE; NONHUMAN; ONCOGENE C MYC; PRIORITY JOURNAL; TUMOR GENE;

ALLELES; ANIMALS; CELL LINEAGE; GENE EXPRESSION PROFILING; GENES, APC; INTESTINAL MUCOSA; INTESTINAL NEOPLASMS; INTESTINES; MICE; TRANSCRIPTION INITIATION SITE;

EID: 77954353937     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-09-4593     Document Type: Article

References (59)

1. Mariadason JM, Nicholas C, L'Italien KE, et al. Gene expression profiling of intestinal epithelial cell maturation along the crypt-villus axis. Gastroenterology 2005;128:1081-8. (Pubitemid 40523558)
2. Smartt H, Guilmeau S, Nasser S, et al. p27kip1 regulates cdk2 activity in the proliferating zone of the mouse intestinal epithelium: potential role in neoplasia. Gastroenterology 2007;207: 232-43. (Pubitemid 47031132)
3. Su L-K, Kinzler KW, Vogelstein B, et al. Multiple intestinal neoplasia caused by a mutation in the murine homolog of the APC gene. Science 1992;256:668-70.
4. Fodde R, Edelmann W, Yang K, et al. A targeted chain-termination mutation in the mouse Apc gene results in multiple intestinal tumors. Proc Natl Acad Sci U S A 1994;91:8969-73.
5. Levy DB, Smith KJ, Beazer-Barclay Y, Hamilton SR, Vogelstein B, Kinzler KW. Inactivation of Both APC alleles in human and mouse tumors. Cancer Res 1994;54:5953-8. (Pubitemid 24375233)
6. Yang K, Edelmann W, Fan K, et al. A mouse model of human familial adenomatous polyposis. J Exp Zoolog 1997;277:245-54. (Pubitemid 27134192)
7. Oshima M, Oshima H, Kitagawa K, et al. Loss of Apc heterozygosity and abnormal tissue building in nascent intestinal polyps in mice carrying a truncated Apc gene. Proc Natl Acad Sci U S A 1995;92:4482-6.
8. Knudson AG, Jr. Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci U S A 1971;68:820-3.
9. Knudson AG. Hereditary cancer, oncogenes and antioncogenes. Cancer Res 1985;45:1437-43.
10. Li Q, Ishikawa TO, Oshima M, Taketo MM. The threshold level of adenomatous polyposis coli protein for mouse intestinal tumorigenesis. Cancer Res 2005;65:8622-7. (Pubitemid 41377347)
11. Lipkin M, Blattner WE, Fraumeni JF, Lynch HT, Deschner E, Winawer S. Tritiated thymidine (0p,0h)labeling distribution as a marker for hereditary predisposition to colon cancer. Cancer Res 1983;43:1899-904. (Pubitemid 13122601)
12. Sancho E, Batlle E, Clevers H. Live and let die in the intestinal epithelium. Curr Opin Cell Biol 2003;15:763-70. (Pubitemid 37487970)
13. Yang WC, Mathew J, Velcich A, et al. Targeted inactivation of the p21 WAF1/cip1 gene enhances Apc initiated tumor formation and the tumor promoting activity of a Western-style high risk diet by altering cell maturation in the intestinal mucosa. Cancer Res 2001;61: 565-9.
14. Capodieci P, Donovan M, Buchinsky H, et al. Gene expression profiling in single cells within tissue. Nat Methods 2005;2:663-5. (Pubitemid 41223092)
15. Levsky JM, Shenoy SM, Pezo RC, Singer RH. Single-cell gene expression profiling. Science 2002;297:836-40.
16. Wilson AJ, Velcich A, Arango D, et al. Novel detection and differential utilization of a c-myc transcriptional block in colon cancer chemoprevention. Cancer Res 2002;62:6006-10. (Pubitemid 35244443)
17. Pezo R, Gandhi S, Shirley L, Pestell R, Augenlicht L, Singer R. Single-cell profiling of transcription site activation predicts chemotherapeutic response of human colorectal tumor cells. Cancer Res 2008;68: 4977-82.
18. Maier S, Daroqui CM, Scherer S, et al. Butyrate and vitamin D3 induce transcriptional attenuation at the cyclin D1 locusin colonic carcinoma cells. J Cell Physiol 2009;218:638-42.
19. Larson DR, Singer RH, Zenklusen D. A single molecule view of gene expression. Trends Cell Biol 2009;19:630-7.
20. Darzacq X, Yao J, Larson DR, et al. Imaging transcription in living cells. Annu Rev Biophys 2009;38:173-96.
21. Tetsu O, McCormick F. β-Catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature 1999;398:422-6. (Pubitemid 29180374)
22. Shtutman M, Zhurinsky J, Simcha I, et al. The cyclin D1 gene is a target of the B-catenin/LEF-1 pathway. Proc Natl Acad Sci U S A 1999;96:5522-7.
23. He T-C, Sparks AB, Rago C, et al. Identification of c-MYC as a target of the APC pathway. Science 1998;281:1509-12.
24. Guilmeau S, Flandez M, Bancroft L, et al. Intestinal deletion of protein O-fucosyltransferase in the mouse inhibits Notch signaling and causes entero-colitis. Gastroenterology 2008;135:849-60.
25. Flandez M, Guilmeau S, Blache P, Augenlicht LH. KLF4 regulation in intestinal epithelial cell maturation. Exp Cell Res 2008;314: 3712-23.
26. Yang K, Edelmann W, Fan K, et al. Dietary modulation of carcinoma development in a mouse model for human familial polyposis. Cancer Res 1998;58:5713-7.
27. Yang K, Kurihara N, Fan K, et al. Dietary induction of colonic tumors in a mouse model of sporadic colon cancer. Cancer Res 2008;68: 7803-10.
28. Yang W, Bancroft L, Nicholas C, Lozonschi I, Augenlicht LH. Targeted inactivation of p27kip1 is sufficient for large and small intestinal tumorigenesis in the mouse, which can be augmented by a western-style high-risk diet. Cancer Res 2003;63:4990-6.
29. Yang W, Velcich A, Lozonschi I, et al. Inactivation of p21WAF1/cip1 enhances intestinal tumor formation in Muc2-/- mice. Am J Pathol 2005;166:1239-46.
30. Website m. Available from: http://www.myccancergene.org/site/mycTargetDB. asp.
31. Ignatenko NA, Holubec H, Besselsen DG, et al. Role of c-Myc in intestinal tumorigenesis of the ApcMin/+ mouse. Cancer Biol Ther 2006;5:1658-64. (Pubitemid 46256645)
32. Sansom OJ, Meniel VS, Muncan V, et al. Myc deletion rescues Apc deficiency in the small intestine. Nature 2007;446:676-9. (Pubitemid 46606884)
33. Fre S, Huyghe M, Mourikis P, Robine S, Louvard D, Artavanis-Tsakonas S. Notch signals control the fate of immature progenitor cells in the intestine. Nature 2005;435:964-8. (Pubitemid 40896323)
34. Yang Q, Bermingham NA, Finegold MJ, Zoghbi HY. Requirement of Math1 for secretory cell lineage commitment in the mouse intestine. Science 2001;294:2155-8. (Pubitemid 33150670)
35. Jensen J, Pedersen EE, Galante P, et al. Control of endodermal endocrine development by Hes-1. Nat Genet 2000;24:36-44. (Pubitemid 30041417)
36. Guzy RD, Sharma B, Bell E, Chandel NS, Schumacker PT. Loss of the SdhB, but Not the SdhA, subunit of complex II triggers reactive oxygen species-dependent hypoxia-inducible factor activation and tumorigenesis. Mol Cell Biol 2008;28:718-31.
37. Keith B, Simon MC. Hypoxia-inducible factors, stem cells, and cancer. Cell 2007;129:465-72. (Pubitemid 46660978)
38. Mahmoud NN, Boolbol SK, Bilinski RT, Martucci C, Chadburn A, Bertagnolli MM. Apc gene mutation is associated with a dominant-negative effect upon intestinal cell migration. Cancer Res 1997;57: 5045-50. (Pubitemid 27498118)
39. Mahmoud NN, Bilinski RT, Churchill MR, Edelmann W, Kucherlapati R, Bertagnolli MM. Genotype-phenotype correlation in murine Apc mutation: differences in enterocyte migration and response to sulindac. Cancer Res 1999;59:353-9.
40. Smits R, Kartheuser A, Jagmohan-Changur S, et al. Loss of Apc and the entire chromosome 18 but absence of mutations at the Ras and Tp53 genes in intestinal tumors from Apc1638N, a mouse model for Apc-driven carcinogenesis. Carcinogenesis 1997;18: 321-7.
41. Yang K, Popova N, Yang W, et al. Interaction of Muc2 and Apc on Wnt signaling and in intestinal tumorigenesis: potential role of chronic inflammation. Cancer Res 2008;68:7313-22.
42. Barker N, Ridgway RA, van Es JH, et al. Crypt stem cells as the cells-of-origin of intestinal cancer. Nature 2009;457:608-11.
43. Augenlicht LH, Anthony GM, Chruch TL, et al. Short chain fatty acid metabolism, apoptosis and Apc initiated tumorigenesis in the mouse gastrointestinal mucosa. Cancer Res 1999;59:6005-9.
44. Korinek V, Barker N, Moerer P, et al. Depletion of epithelial stem-cell compartments in the small intestine of mice lacking Tcf-4. Nat Genet 1998;19:379-83.
45. Vander Heiden MG, Cantley LC, Thompson CB. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 2009;324:1029-33.
46. Cipolleschi MG, Dello Sbarba P, Olivotto M. The role of hypoxia in the maintenance of hematopoietic stem cells. Blood 1993;82: 2031-7.
47. Danet GH, Pan Y, Luongo JL, Bonnet DA, Simon MC. Expansion of human SCID-repopulating cells under hypoxic conditions. J Clin Invest 2003;112:126-35. (Pubitemid 38056384)
48. Morrison SJ, Csete M, Groves AK, Melega W, Wold B, Anderson DJ. Culture in reduced levels of oxygen promotes clonogenic sympathoadrenal differentiation by isolated neural crest stem cells. J Neurosci 2000;20:7370-6.
49. Ramirez-Bergeron DL, Simon MC. Hypoxia-inducible factor and the development of stem cells of the cardiovascular system. Stem Cells 2001;19:279-86.
50. Studer L, Csete M, Lee SH, et al. Enhanced proliferation, survival, and dopaminergic differentiation of CNS precursors in lowered oxygen. J Neurosci 2000;20:7377-83.
51. Pollard PJ, Briere JJ, Alam NA, et al. Accumulation of Krebs cycle intermediates and over-expression of HIF1α in tumours which result from germline FH and SDH mutations. Hum Mol Genet 2005;14: 2231-9.
52. King A, Selak MA, Gottlieb E. Succinate dehydrogenase and fumarate hydratase: linking mitochondrial dysfunction and cancer. Oncogene 2006;25:4675-82. (Pubitemid 44187617)
53. Koivunen P, Hirsila M, Remes AM, Hassinen IE, Kivirikko KI, Myllyharju J. Inhibition of hypoxia-inducible factor (HIF) hydroxylases by citric acid cycle intermediates: possible links between cellmetabolism and stabilization of HIF. J Biol Chem 2007;282:4524-32.
54. Chandel NS, Maltepe E, Goldwasser E, Mathieu CE, Simon MC, Schumacker PT. Mitochondrial reactive oxygen species trigger hypoxia-induced transcription. Proc Natl Acad Sci U S A 1998;95: 11715-20.
55. Shackelford DB, Vasquez DS, Corbeil J, et al. mTOR and HIF-1α-mediated tumor metabolism in an LKB1 mouse model of Peutz-Jeghers syndrome. Proc Natl Acad Sci U S A 2009;106: 11137-42.
56. Albuquerque C, Breukel C, van der Luijt R, et al. The "just-right" signaling model: APC somatic mutations are selected based on a specific level of activation of the β-catenin signaling cascade. Hum Mol Genet 2002;11:1549-60.
57. Oyama T, Yamada Y, Hata K, et al. Further upregulation of {β}-catenin/Tcf transcription is involved in the development of macroscopic tumors in the colon of Apc Min/+ mice. Carcinogenesis 2008;29:666-72.
58. Kielman MF, Rindapaa M, Gaspar C, et al. Apc modulates embryonic stem-cell differentiation by controlling the dosage of β-catenin signaling. Nat Genet 2002;32:594-605.
59. Cook DL, Gerber AN, Tapscott SJ. Modeling stochastic gene expression: implications for haploinsufficiency. Proc Natl Acad Sci U S A 1998;95:15641-6.